Search results

Found 150 pages
AUTHOR: PharmaTimes Reporter

Results per page

10 20 50 100

Sort by

Relevance Date

29 May 2015:

NICE recommends new licences for autoinflammatory disorders

After two months of not issuing guidance due to the UK’s General Election, NICE has today published a host of new recommendations for a number of drugs. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/nice_recommends_new_licences_for_autoinflammatory_disorders_971452

28 Sep 2017:

NICE knocks-back Janssen's Imbruvica in mantle cell lymphoma

But recommends it for the rare cancer Waldenstrom’s macroglobulinaemia - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/nice_knocks-back_janssens_imbruvica_in_mantle_cell_lymphoma_1206533

19 May 2017:

Mixed fortunes continue for Ionis rare disease drug inotersen

Meets its Phase III targets but concerns remain over its side effects profile - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/mixed_fortunes_continue_for_ionis_rare_disease_drug_inotersen_1193035

26 May 2015:

Sanofi’s Jevtana given last-minute CDF reprieve

Sanofi has reached an eleventh hour reprieve with NHS England that will see its advanced prostate cancer drug Jevtana (cabazitaxel) once more become available on the NHS. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/sanofis_jevtana_given_last-minute_cdf_reprieve_971446

24 Feb 2017:

Better diabetic foot care 'could save NHS £250m'

NHS England could significantly cut its spending on diabetes foot care by introducing or rearranging specialist foot services, according to a leading charity. - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/better_diabetic_foot_care_could_save_nhs_250m_1187552

27 May 2015:

Bayer plans corporate restructure

Bayer is developing plans to overhaul its corporate structure to more closely align its two life sciences businesses, but says the move will not see any staff reductions. - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/bayer_plans_corporate_restructure_971447

17 Mar 2015:

Novartis' Jakavi gets yes in Europe

Novartis has been given the green light in Europe for Jakavi to treat a rare blood cancer.  - News - PharmaTimes

by PharmaTimes Reporter

https://www.pharmatimes.com/news/novartis_jakavi_gets_yes_in_europe_971191

19 May 2017:

Astellas completes 800 million euro biotech acquisition

Belgium’s Ogeda is now a wholly-owned subsidiary of the Japanese pharma firm - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/astellas_completes_800_million_euro_biotech_acquisition_1193032

19 May 2017:

Alzheimer’s research seeing 'exceptionally high levels' of innovation

Nearly two-thirds of pipeline products have first-in-class potential - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/alzheimers_research_seeing_exceptionally_high_levels_of_innovation_1193028

27 Sep 2017:

UK CRO Quanticate doubles its footprint in India

Opens new Bangalore office to bolster its global offering - News - PharmaTimes

by PharmaTimes reporter

https://www.pharmatimes.com/news/uk_cro_quanticate_doubles_its_footprint_in_india_1206470